Search the Newsreel

VAREX IMAGING (VREX) Q3 Earnings Beat Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO

On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), today announced the optimization of …

Varex Imaging (NASDAQ:VREX) Issues Earnings Results

Teledyne to acquire Varex Imaging for $1.1 billion in cash

Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $1.1 billion in cash, including equity awards and net debt. The deal, unanimously approved by both boards, will see Teledyne pay $18.90 per share. Varex, a developer of X-ray sources and …

Varex Imaging (VREX) swings to Q3 profit with margin gains and tariff refund boost

Varex Imaging (VREX) reported a swing to profit in Q3 fiscal 2026, with GAAP net income of $15.7 million compared to a significant loss a year prior. The company saw a 4% year-over-year increase in total revenue to $210.5 million, boosted by a $17 …

Teledyne to Acquire Varex Imaging Corporation

THOUSAND OAKS, Calif. & SALT LAKE CITY, August 10, 2026--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) ("Teledyne") and Varex Imaging Corporation (NASDAQ:VREX) ("Varex") jointly announced today that they have entered into a definitive agreement under which Teledyne will acquire all of the outstanding common shares of …

IMAX's 'The Odyssey' Sets Box Office Record

IMAX's film 'The Odyssey' has achieved a significant box office milestone, becoming its highest-grossing film of all time with $289 million in ticket sales globally. The movie continues to perform strongly, adding $37 million in its fourth weekend, with IMAX theaters contributing 26% of …

Renaissance Technologies LLC Sells 216,300 Shares of IMAX Corporation $IMAX

Renaissance Technologies LLC significantly reduced its stake in IMAX Corporation by 74.5% in the first quarter, selling 216,300 shares and retaining 74,100 shares. Despite this sell-off, other institutional investors increased their holdings, with institutional investors collectively owning 93.51% of IMAX. Analysts maintain a "Moderate …

Morimatsu Launches HK$50 Million On-Market Share Buyback Plan

Optima Health Sets Date for Full‑Year Results and Analyst Briefing

YPF Sociedad Anónima (YPF) Earnings Date and Reports 2026 $YPF

Varex Imaging Corp (VREX) Earnings Date & Reports & Earnings News

YPF Sociedad Anónima (NYSE:YPF) Given Consensus Rating of "Hold" by Brokerages

YPF Sociedad Anónima (NYSE:YPF) has received a consensus "Hold" rating from five brokerage firms, with three recommending a hold and two a buy. The average 12-month price target is $46.00, which is below its current share price of $49.20. Despite beating Q1 earnings expectations, …

Nano-X Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

Rosen Law Firm is reminding investors of Nano-X Imaging Ltd. (NASDAQ: NNOX) who purchased securities between March 31, 2025, and April 17, 2026, about the August 11, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Nano-X made false and …

Is TriMas (TRS) Undervalued On Earnings And Buybacks?

Elanco Animal Health Number of Employees 2026 | Employee Count & Headcount Data

Elanco Animal Health (ELAN) had approximately 10,025 employees worldwide as of March 2026, marking a 2.8% growth since 2023. The company is actively hiring, with 772 job postings in 2026, a 40.1% increase from 2025. Its workforce is primarily concentrated in North America, and …

Himax Technologies (HIMX) Stock Rebound Faces Margin Pressure And 72x P E

Himax Technologies (HIMX) recently saw a 6.3% stock jump following better-than-expected Q2 2026 earnings, reporting US$0.23 EPS on US$227.4m revenue. However, the company faces significant margin pressure, with its trailing net profit margin halved to 4.3% compared to the prior year. Despite product wins …

Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win?

Elanco Animal Health (ELAN) reported stronger Q2 sales and net income, along with an FDA Emergency Use Authorization for its CLiK Extra screwworm-prevention spray. The company also raised its full-year revenue guidance, positioning it as a key player in addressing the New World screwworm …

VREX Looks 11.5% Undervalued on GF Value™ as It Prepares Q3 Earnings

Varex Imaging Corp (VREX) is set to release its Q3 earnings on August 10, with analysts forecasting increased EPS and revenue. Despite facing profitability and cash flow challenges, the company appears 11.5% undervalued according to GuruFocus' GF Value™ metric, though this should be interpreted …

NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ:NNOX) on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026. The lawsuit alleges that Nano-X made materially false and misleading statements regarding its …

Nano-X Imaging Raises $8 Million in Registered Direct Offering Completed on August 7, 2026

Nano-X Imaging (NNOX) announced the completion of an $8 million registered direct offering on August 7, 2026, to a single institutional investor. The company issued 8 million ordinary shares or pre-funded warrants along with 8 million purchase warrants, with proceeds intended for working capital …

Enterprise value to revenue forward of Universus Photo Imagings Ltd – NSE:UNIVPHOTO

Renaissance Technologies LLC Has $3.33 Million Position in Larimar Therapeutics, Inc. $LRMR

Renaissance Technologies LLC significantly increased its stake in Larimar Therapeutics, Inc. (NASDAQ:LRMR) by 148.9% in the first quarter, now holding 739,942 shares valued at approximately $3.33 million. Institutional investors and hedge funds collectively own 91.92% of LRMR. Insider buying also occurred, with Director Thomas …

Imagicaaworld Entertainment PAT rises 29.9% in Q1FY27 on park volume surge

Digimarc (DMRC) to Release Quarterly Earnings on Monday

Digimarc (NASDAQ:DMRC) is scheduled to release its Q2 2026 earnings after market close on Monday, August 10th. Analysts anticipate a loss of $0.33 per share and revenue of approximately $7.09 million. The company previously exceeded expectations in Q1, but maintains negative net margins and …

Douglas Elliman (DOUG) Stock Slips As Losses Ease But Risks Linger

Douglas Elliman (DOUG) stock slipped 0.6% after its Q2 2026 report, which showed a significant narrowing of losses and a revenue increase, contributing to cautious optimism. Despite improved income statement trends and positive short-term indicators, risks remain due to year-to-date losses and reliance on …

Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Is Elanco Animal Health (ELAN) Undervalued Following Its FDA Emergency Use Authorization?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Investors in Digimarc Corporation (DMRC): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025

Levi & Korsinsky LLP has filed a class action securities lawsuit against Digimarc Corporation (DMRC) on behalf of investors who suffered losses between May 3, 2024, and February 26, 2025. The lawsuit alleges that Digimarc made false statements and concealed that a large commercial …

GETTY IMAGES Q2 2026 Earnings Preview: Recent $GETY Insider Trading, Hedge Fund Activity, and More

VAREX IMAGING Q3 2026 Earnings Preview: Recent $VREX Insider Trading, Hedge Fund Activity, and More

Analysts’ Opinions Are Mixed on These Technology Stocks: Himax Technologies (HIMX), AvePoint (AVPT) and nLIGHT (LASR)

This article summarizes recent analyst ratings for three technology stocks: Himax Technologies (HIMX), AvePoint (AVPT), and nLIGHT (LASR). Himax Technologies received a "Buy" rating with a $43.00 price target from Robert W. Baird, while AvePoint was given a "Hold" rating by William Blair. nLIGHT …

Varex Imaging Corp (VREX) Stock News Today

This article provides current stock information for Varex Imaging Corp (VREX), including its latest stock price, market capitalization, and a note indicating that more news is coming soon. The stock closed at $12.410, up 1.31%, with a market cap of $523.04 million. It also …

AMC, IMAX, CNK Stocks In Focus: Strong Q2 Box Office Since 2019 Revives Theatre Trade

The second quarter of 2026 marked the best Q2 for the domestic box office since 2019, generating $2.974 billion and boosting investor confidence in cinema chains like AMC, Cinemark, and IMAX. This strong performance, driven by blockbuster releases like "The Super Mario Galaxy Movie," …

Imax Corp (IMAX) Insider Sell: SVP, Controller & PAO Jose Zlatar Sells 500 Shares

Imax Corp's SVP, Controller & PAO Jose Zlatar sold 500 shares of the company on August 6, 2026, for approximately $24,950. This sale contributes to a pattern of 16 insider sells and zero insider buys over the past year, indicating a potential lack of …

Lumexa Imaging (NASDAQ:LMRI) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Lumexa Imaging (NASDAQ:LMRI) from a "buy" to a "hold" rating, despite the broader analyst consensus remaining a "Moderate Buy" with a $16.00 price target. Lumexa shares opened at $11.58, and institutional investors like BlackRock Inc. have recently increased their …